CL
VKTX icon

CSS LLC’s Viking Therapeutics VKTX Stock Holding History

CSS LLC’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,258
Closed -$131K – 1109
2022
Q3 		$80K Hold
29,258
– – ﹤0.01% 839
2022
Q2 		$85K Hold
29,258
– – ﹤0.01% 903
2022
Q1 		$88K Buy
29,258
+10,000
+52% +$35.9K ﹤0.01% 951
2021
Q4 		$89K Hold
19,258
– – ﹤0.01% 1035
2021
Q3 		$121K Hold
19,258
– – 0.01% 951
2021
Q2 		$115K Hold
19,258
– – ﹤0.01% 926
2021
Q1 		$122K Buy
19,258
+2,258
+13% +$15.9K 0.01% 818
2020
Q4 		$96K Hold
17,000
– – ﹤0.01% 714
2020
Q3 		$99K Sell
17,000
-1,000
-6% -$6.89K ﹤0.01% 666
2020
Q2 		$130K Sell
18,000
-20,000
-53% -$133K 0.01% 527
2020
Q1 		$178K Buy
38,000
+32,500
+591% +$200K 0.01% 443
2019
Q4 		$44K Buy
+5,500
New +$40.1K ﹤0.01% 605

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CSS LLC's VKTX Position: Q4 2022 in Review

CSS LLC sold out of Viking Therapeutics (VKTX) in Q4 2022, closing a stake of 29,258 shares — an estimated $131K sold.

CSS LLC first reported a position in VKTX in Q4 2019 and held it in 12 quarters. The position peaked at $178K in Q1 2020. 129 funds tracked by Wall St. Rank hold VKTX as of Q4 2022.

  • CSS LLC reported no remaining Viking Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 29,258 Viking Therapeutics shares in Q4 2022, an estimated $131K.
  • CSS LLC first reported a position in Viking Therapeutics in Q4 2019 and held it in 12 quarters.
  • CSS LLC's Viking Therapeutics position peaked at $178K in Q1 2020.
  • 129 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.